Pharmacotherapy of CSA: who, when and how?

S. Javaheri (Cincinnati, United States of America)

Source: Sleep and Breathing Conference 2021
Session: Current knowledge and research priorities in central sleep apnoea
Session type: Symposium
Number: 0

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Javaheri (Cincinnati, United States of America). Pharmacotherapy of CSA: who, when and how?. Sleep and Breathing Conference 2021

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Positional therapy: who, when and how?
Source: Sleep and Breathing Conference 2021
Year: 2021

Practical approach to the difficult-to-wean patient: who, how and where?
Source: ERS Skills Course 2016
Year: 2016

Medical therapy of sarcoidosis: who to treat and how?
Source: Annual Congress 2012 - PG8 State-of-the-art management of sarcoidosis
Year: 2012

Long-term oral antibiotic treatment: why, what, when and to whom?
Source: Eur Respir Monogr 2017; 75: 185-205
Year: 2017

Women and COPD: do we need more evidence?
Source: Eur Respir Rev, 28 (151) 180055; 10.1183/16000617.0055-2018
Year: 2019

Education and information for patients with bronchiectasis: What do patients want?
Source: Annual Congress 2011 - What do individuals know about their disease? Educational needs, the psychological impact of chronic respiratory disease and health-related quality of life
Year: 2011

Lung transplantation: who, when?
Source: ISSN=ISSN 1810-6838, ISBN=, page=220
Year: 2006

Initial outpatient management of PE: who and how?
Source: International Congress 2018 – Pulmonary embolism: what we need to know
Year: 2018

Asthma control test: how? And where?
Source: Annual Congress 2008 - Asthma control or asthma severity
Year: 2008

Clustering in asthma: why, how and for how long?
Source: Eur Respir J 2013; 41: 1247-1248
Year: 2013

Identifying the unmet needs in asthma: Who, why and how many?
Source: International Congress 2014 – Identifying the unmet needs in asthma: Who, why and how many?
Year: 2014

“When you’re at work you’ve got a goal [..] but that’s all finished for me now”; exploring goal perception amongst people with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2017 – Latest insights into chronic care
Year: 2017

Update on severe asthma: what we know and what we need
Source: Eur Respir Rev 2009; 18: 58-65
Year: 2009

Managing severe asthma: do we need to do more?
Source: Annual Congress 2007 - Changing practice with anti-IgE: patient, physician and payor perspectives
Year: 2007

Immunotherapy: when, who and which drug?
Source: International Congress 2018 – New drugs, strategies and research designs for advanced non-small cell lung cancer
Year: 2018

The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021

Perspective of a pulmonologist: what might we expect and what do we need to know?
Source: Eur Respir Monogr 2015; 68: 261-273
Year: 2015